Adult and Pediatric Urology P.C.

Omaha, Nebraska 68114

1 studies enrolling now · 3 studies all time

What they study most

Intermediate Risk Non-Muscle Invasive Bladder Cancer, Overactive Bladder, Prostate Cancer

Studies at this site

• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate — Completed
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed